Goodrich to Provide Carbon Brakes and Boltless Wheels to USAF C-130's

Goodrich Corporation (NYSE:GR) has been awarded a contract by the Defense Logistics Agency - Ogden to provide new carbon brakes and boltless wheels for the Air Force's fleet of C-130 transport aircraft. The selection is expected to generate up to $400 million in revenue over the life of the program, including original equipment and aftermarket sales for U.S. and international customers. The contract covers qualification activities as well as flight test and retrofit equipment. The equipment will be provided by Goodrich's Aircraft Wheels and Brakes business.

"Our C-130 wheel and brake design incorporates innovative solutions from our unique experience with large boltless aircraft wheels, as well as our high-performance DURACARBTM carbon braking material," said Brian Brandewie, president, Aircraft Wheels and Brakes, Goodrich. "We believe the low-risk design and validation approach used by the Air Force as part of the source selection criteria combined with our advanced aircraft wheel and brake technologies will provide the C-130 community with significant performance, cost and maintainability benefits throughout the life of the program."

Goodrich DURACARB(TM) carbon braking systems provide lighter weight, longer life, higher performance and lower cost of ownership compared to steel braking systems. Goodrich boltless aircraft wheels employ a lock-ring design that dramatically lowers maintenance time and cost, as well as parts count, when compared to traditional bolted aircraft wheels. Goodrich aircraft wheels and carbon brakes are in service on approximately 9,500 military, commercial, regional and business aircraft produced by Airbus, Boeing, Bombardier, Cessna, Embraer, Lockheed Martin and Northrop Grumman.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.